He Miao, Smith Laurie D, Chang Richard, Li Xueli, Vockley Jerry
Department of Pathology and Laboratory Medicine, University of Pennsylvania, PA 19104, USA.
Department of Pediatrics, Children's Mercy Hospital, Kansas City, MO 64108, USA.
Biochim Biophys Acta. 2014 Mar;1841(3):331-5. doi: 10.1016/j.bbalip.2013.10.009. Epub 2013 Oct 18.
Deficiency of sterol C4 methyl oxidase, encoded by the SC4MOL gene, has recently been described in four patients from three different families. All of the patients presented with microcephaly, congenital cataracts, and growth delay in infancy. The first patient has suffered since the age of six years from severe, diffuse, psoriasiform dermatitis, sparing only her palms. She is now 20 years old. The second patient is a 5 year old girl who has just started to develop dry skin and hair changes. The third and fourth patients are a pair of affected siblings with a severe skin condition since infancy. Quantitative sterol analysis of plasma and skin scales from all four patients showed marked elevation of 4α-methyl- and 4, 4'-dimethylsterols, consistent with a deficiency in the first step of sterol C4 demethylation in cholesterol biosynthesis. Mutations in the SC4MOL have been identified in all of the patients. SC4MOL deficiency is the first autosomal recessive disorder identified in the sterol demethylation complex. Cellular studies with patient-derived fibroblasts have shown a higher mitotic rate than control cells in cholesterol-depleted medium, with increased de novo cholesterol biosynthesis and accumulation of methylsterols. Immunologic analyses of granulocytes and B cells from patients and obligate carriers in the patients' families indicated dysregulation of immune-related receptors. Inhibition of sterol C4 methyl oxidase in human transformed lymphoblasts induced activation of the cell cycle. Additional studies also demonstrated diminished EGFR signaling and disrupted vesicular trafficking in cells from the affected patients. These findings suggest that methylsterols play an important role in epidermal biology by their influence on cell proliferation, intracellular signaling, vesicular trafficking and immune response. SC4MOL is situated within the psoriasis susceptibility locus PSORS9, and may be a genetic risk factor for common skin conditions. This article is part of a Special Issue entitled The Important Role of Lipids in the Epidermis and their Role in the Formation and Maintenance of the Cutaneous Barrier. Guest Editors: Kenneth R. Feingold and Peter Elias.
由SC4MOL基因编码的固醇C4甲基氧化酶缺乏症最近在来自三个不同家庭的四名患者中被发现。所有患者均表现为小头畸形、先天性白内障和婴儿期生长发育迟缓。第一名患者自6岁起就患有严重的、弥漫性的银屑病样皮炎,仅手掌未受累。她现在20岁。第二名患者是一名5岁女孩,刚刚开始出现皮肤干燥和毛发变化。第三名和第四名患者是一对患病的兄弟姐妹,自婴儿期起就患有严重的皮肤疾病。对所有四名患者的血浆和皮肤鳞屑进行的定量固醇分析显示,4α-甲基和4,4'-二甲基固醇显著升高,这与胆固醇生物合成中固醇C4去甲基化第一步的缺乏一致。在所有患者中均已鉴定出SC4MOL基因的突变。SC4MOL缺乏症是在固醇去甲基化复合物中鉴定出的首个常染色体隐性疾病。对患者来源的成纤维细胞进行的细胞研究表明,在胆固醇缺乏的培养基中,其有丝分裂率高于对照细胞,同时从头胆固醇生物合成增加,甲基固醇积累。对患者及其家族中必然携带者的粒细胞和B细胞进行的免疫学分析表明,免疫相关受体存在失调。在人转化淋巴细胞中抑制固醇C4甲基氧化酶可诱导细胞周期激活。额外的研究还表明,受影响患者的细胞中表皮生长因子受体(EGFR)信号减弱,囊泡运输受阻。这些发现表明,甲基固醇通过影响细胞增殖、细胞内信号传导、囊泡运输和免疫反应,在表皮生物学中发挥重要作用。SC4MOL位于银屑病易感位点PSORS9内,可能是常见皮肤疾病的遗传危险因素。本文是名为“脂质在表皮中的重要作用及其在皮肤屏障形成和维持中的作用”特刊的一部分。客座编辑:肯尼斯·R·费因戈尔德和彼得·埃利亚斯。